newsfilter
← Latest News
PR Newswire·

Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate

NEW YORK, April 26, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the submission of an investigational new drug application ("IND") to the United States Food and Drug Administration ("FDA") for its immuno-oncology RNA therap